FARFROMBORING PROMOTIONS.COM, LLC – Trademark Portfolio
Entity Type: 16
FARFROMBORING PROMOTIONS.COM, LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SAFETY FIRST. The owner is based in Boca Raton, FL.
Suite 210
6401 Congress Ave
Boca Raton, FL 33487
Showing of trademarks Trademarks
Trademark Classifications
FARFROMBORING PROMOTIONS.COM, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does FARFROMBORING PROMOTIONS.COM, LLC have?
FARFROMBORING PROMOTIONS.COM, LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 2 cancelled.
What trademark classes does FARFROMBORING PROMOTIONS.COM, LLC file in?
FARFROMBORING PROMOTIONS.COM, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 21 (Housewares). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are FARFROMBORING PROMOTIONS.COM, LLC's most well-known trademarks?
FARFROMBORING PROMOTIONS.COM, LLC's registered trademark portfolio includes well-known marks such as SAFETY FIRST. These are among 1 currently registered trademark in the portfolio.
What is FARFROMBORING PROMOTIONS.COM, LLC's trademark registration success rate?
FARFROMBORING PROMOTIONS.COM, LLC has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.